£378k
+13%vs Jul 2024Active11798939Private limited companyOxford
NEWROTEX LIMITED
Significant control: Friedrich Wilhelm Ludwig Paul Vollrath (25–50%), Alexander Kristian Woods (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Newrotex Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Newrotex Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
NEWROTEX LIMITED is an active private limited company (company number 11798939) incorporated on 31 January 2019, registered in Oxford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 July 2025, showing net assets of £378k, with 7 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 13% on the prior period (£333k).
Peer position · net assets
By net assets it sits in the upper half of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
02
Ownership and control
- Dr Friedrich Wilhelm Ludwig Paul Vollrath
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Alexander Kristian Woods
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 31 January 20197 yrs ago
- Next accounts due
- 30 April 2027in 186 days
- Confirmation statement due
- 14 February 2027in 111 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
7
+40%vs Jul 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 July 2025 | £378k | — | — | — | — | — | 7 |
| 31 July 2024 | £333k | — | — | — | — | — | 5 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £378,079 at 31 July 2025
- Net assets up 10% or more on the prior period+13.4% vs prior period
- Incorporated five or more years agoIncorporated 31 January 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 186 days
- Confirmation statement duein 111 days
- Accounts period endNet assets £378k · micro accounts
- Accounts period endNet assets £333k · micro accounts
- Incorporated
08
Similar companies in Oxford
- OMICS CONSULTANCY LTDOxford · inc. Jan 2019
- BIOMODIFY LTDBicester · inc. Feb 2019
- TRUCS THERAPEUTICS LIMITEDBicester · inc. Jan 2019
- HOLOS LIFE SCIENCES (UK) LIMITEDOxford · inc. Mar 2019
- OXFORD CLINICAL RESEARCH LTD.Oxford · inc. Mar 2019
- RATIONAL VACCINES UK LIMITEDWantage · inc. Mar 2019
All companies incorporated on 31 January 2019 · in Jan 2019.
09
Reminders for NEWROTEX LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.